Helius Medical Technologies Inc is trading at $1.69 (5.7% up) in after-hours trading, rebounding modestly after its recent drop following the rejection of an all-stock acquisition proposal from Forward Industries.
- The company's board recently declined a buyout offer that valued shares in the mid-$1 range, prompting traders to reassess the company’s standalone prospects.
- The stock is experiencing follow-through volatility as investors react to the company's decision to remain an independent entity.